Life Science REIT Future Growth

Future criteria checks 4/6

Life Science REIT is forecast to grow earnings and revenue by 107.7% and 6.3% per annum respectively while EPS is expected to grow by 98.7% per annum.

Key information

107.7%

Earnings growth rate

98.7%

EPS growth rate

Health Care REITs earnings growth26.8%
Revenue growth rate6.3%
Future return on equityn/a
Analyst coverage

Low

Last updated07 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:LABS - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202622325163
12/31/202518213143
12/31/202415-131102
6/30/202420-40-1812N/A
3/31/202420-31-1710N/A
12/31/202320-22-168N/A
9/30/202320-25-137N/A
6/30/202319-29-97N/A
3/31/202318-28-93N/A
12/31/202216-28-9-1N/A
12/31/202111988N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LABS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).

Earnings vs Market: LABS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: LABS is expected to become profitable in the next 3 years.

Revenue vs Market: LABS's revenue (6.3% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: LABS's revenue (6.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if LABS's Return on Equity is forecast to be high in 3 years time


Discover growth companies